Eric Broyles

Nanocan Therapeutics Corporation is an early-stage biotechnology company that develops nanotechnology-based innovations to treat cancers where current interventions are insufficient. The company is based in Princeton, NJ. The company aims to create a new standard of care for cancer patients through its partnerships with leading academic research institutions. Nanocan is committed to making its disruptive innovations available to cancer patients in low and middle-income countries. The company was founded by Jacques Walker and Eric Broyles, and Eric Broyles has been the CEO since incorporation.

Gerson Lehrman Group, Inc. provides membership network for learning and expertise. The firm promotes knowledge exchange through conversations, small group convenings, mentorships, surveys, and other interactions with its network of experts. The company was founded by Alexander Saint-Amand, Thomas D. Lehrman, and Mark Gerson in 1998 and is headquartered in New York, NY.